#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13980	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2169	634.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1392	1392	C	797	C	776	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25418	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3420	734.9	0	.	n	.	0	T695C	SNP	695	695	T	957	957	C	716	C,T	694,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25418	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3420	734.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2233	2233	C	800	C,T	767,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25418	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3420	734.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2307	2307	A	785	A	762	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25418	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3420	734.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2859	2859	C	771	C	744	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1706	folP	855	855	100.0	folP.l15.c4.ctg.1	1362	123.2	1	SNP	p	R229S	1	.	.	685	687	AGC	957	959	AGC	168;168;172	A;G;C	167;166;170	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5230	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3363	154.3	1	SNP	p	S91F	1	.	.	271	273	TTC	574	576	TTC	154;152;153	T;T;C	151;149;147	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5230	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3363	154.3	1	SNP	p	G95N	0	.	.	283	285	GGC	586	588	GGC	160;158;155	G;G;C	156;154;151	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5230	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3363	154.3	1	SNP	p	D95G	1	.	.	283	285	GGC	586	588	GGC	160;158;155	G;G;C	156;154;151	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1576	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1415	110.4	1	SNP	p	G45D	0	.	.	133	135	GGC	509	511	GGC	190;186;183	G;G;C	186;181;179	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	878	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1006	86.1	0	.	n	.	0	A197.	DEL	197	197	A	586	586	A	213	A	211	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4308	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	141.0	1	SNP	p	D86N	0	.	.	256	258	GAC	618	620	GAC	177;176;179	G,C;A;C	172,1;166;177	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4308	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	141.0	1	SNP	p	R87I	0	.	.	259	261	CGT	621	623	CGT	175;171;172	C;G;T	174;170;167	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4308	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	141.0	1	SNP	p	R87W	0	.	.	259	261	CGT	621	623	CGT	175;171;172	C;G;T	174;170;167	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4308	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	141.0	1	SNP	p	S87R	1	.	.	259	261	CGT	621	623	CGT	175;171;172	C;G;T	174;170;167	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4308	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	141.0	1	SNP	p	S88P	0	.	.	262	264	TCC	624	626	TCC	174;175;172	T;C;C	171;173;169	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3934	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2684	145.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1615	1617	GGC	190;189;190	G;G,T;C	185;183,1;184	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3862	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	159.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1281	1283	GCC	230;225;224	G;C;C	220;220;218	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3862	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	159.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1284	1286	ATG	223;222;223	A;T;G	218;214;214	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3862	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	159.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1296	1298	ACC	224;225;229	A;C;C	209;220;222	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3862	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	159.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1296	1298	ACC	224;225;229	A;C;C	209;220;222	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3862	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	159.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1797	1799	ACC	199;200;197	A;C;C	185;190;187	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3862	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	159.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1851	1853	GCG	202;201;203	G;C;G	199;196;197	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3862	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	159.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1851	1853	GCG	202;201;203	G;C;G	199;196;197	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3862	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	159.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1974	1976	GGT	139;137;135	G,A;G;T,C	132,2;132;129,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3862	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	159.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1983	1985	AGC	129;129;127	A,G;G;C	122,2;127;122	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3862	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	159.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2001	2003	CCG	100;101;99	C,G;C,G;G,C	97,1;97,1;86,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5358	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3194	165.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1657	1659	CCG	180;178;178	C,A;C;G,C	161,1;171;164,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2286	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1795	125.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	553	553	C	166	C	162	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	A251V	NONSYN	751	753	GCG	67	69	GTA	24;24;24	G;T;A	22;22;22	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	S271T	NONSYN	811	813	TCG	127	129	ACT	37;35;35	A;C;T	37;35;34	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	133	135	GAT	28;28;25	G;A;T	28;27;25	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	D276N	NONSYN	826	828	GAT	142	144	AAC	28;28;28	A;A;C	28;26;28	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	N277H	NONSYN	829	831	AAC	145	147	CAC	28;28;28	C;A;C	28;28;28	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	R307E	NONSYN	919	921	AGA	235	237	GAA	12;12;12	G;A;A	12;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	T311A	NONSYN	931	933	ACA	247	249	GCA	10;10;10	G;C;A	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	E312D	NONSYN	934	936	GAA	250	252	GAC	10;10;10	G;A;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	F314I	NONSYN	940	942	TTC	256	258	ATC	11;11;11	A;T;C	9;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	A316S	NONSYN	946	948	GCG	262	264	TCG	11;11;11	T;C;G	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	V318A	NONSYN	952	954	GTC	268	270	GCC	11;11;11	G;C;C	10;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	G319S	NONSYN	955	957	GGC	271	273	AGC	11;11;11	A;G;C	10;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	G320A	NONSYN	958	960	GGT	274	276	GCC	11;10;10	G;C;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	311	20.7	0	.	p	.	0	G322V	NONSYN	964	966	GGT	280	282	GTT	10;10;10	G;T;T	10;10;10	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2636	porB1b	1038	1038	99.81	porB1b.l15.c30.ctg.1	1370	188.2	0	.	p	.	0	E209K	NONSYN	625	627	GAA	812	814	AAA	228;230;235	A;A;A	221;226;230	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2636	porB1b	1038	1038	99.81	porB1b.l15.c30.ctg.1	1370	188.2	0	.	p	.	0	A212E	NONSYN	634	636	GCA	821	823	GAA	223;226;227	G,T;A;A	207,1;215;222	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2636	porB1b	1038	1038	99.81	porB1b.l15.c30.ctg.1	1370	188.2	1	SNP	p	G120K	1	.	.	358	360	AAG	545	547	AAG	196;195;198	A,G;A,G;G,T	188,2;190,2;186,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2636	porB1b	1038	1038	99.81	porB1b.l15.c30.ctg.1	1370	188.2	1	SNP	p	A121N	1	.	.	361	363	AAC	548	550	AAC	200;202;203	A,G;A,C;C	194,2;190,2;194	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2636	porB1b	1038	1038	99.81	porB1b.l15.c30.ctg.1	1370	188.2	1	SNP	p	N121D	0	.	.	361	363	AAC	548	550	AAC	200;202;203	A,G;A,C;C	194,2;190,2;194	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9270	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4854	189.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1064	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1092	96.6	1	SNP	p	V57M	1	.	.	169	171	ATG	615	617	ATG	196;200;201	A;T;G	191;194;193	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
